Clinical trial
The Minimal Effective Dose of Antipsychotic Medication in Older Patients With Schizophrenia: a PET Study.
NCT00716755 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Minimal Effective Dose of Antipsychotic Medication in Older Patients With Schizophrenia: a PET Study.
- Lead sponsor
- Centre for Addiction and Mental Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2009
- Completion date
- August 31, 2015
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
delusional disorder, psychotic disorder, schizoaffective disorder, schizophrenia, schizophreniform disorder